Acutaas Chemicals Ltd

Acutaas Chemicals Ltd Share Price Today: Live Updates & Key Insights

Get insights on Acutaas Chemicals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Acutaas Chemicals Ltd Share Price Chart

Acutaas Chemicals Ltd Fundamentals

Traded Volume: 1,83,230

Market Cap(Cr): 14,450

Avg Traded Price 716.03

1 Year return 69.39%

Upper Circuit 1,797

Lower Circuit 1,742

P/E TTM 65.00

P/B Ratio 27.00

Traded Value(Cr) 3234.01

EPS TTM 27.356

Book value 27.356

Dividend 0.00%

Acutaas Chemicals Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Acutaas Chemicals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Acutaas Chemicals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +3.61%

1M +25.77%

3M +34.16%

1Y +69.39%

YTD +69.75%

Acutaas Chemicals Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Acutaas Chemicals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 3.24L

Day Before Yesterday 5.99L

1W Avg 5.07L

1M Avg 4.83L

3M Avg 3.50L

Acutaas Chemicals Ltd Technical Details

Acutaas Chemicals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 1739

Support 2 1713

Support 3 1684

Pivot Point : 1768

Resistance 1 1794

Resistance 2 1823

Resistance 3 1849

Acutaas Chemicals Ltd Corporate Actions

Acutaas Chemicals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Acutaas Chemicals Ltd’s capital allocation strategies.

All

Ex-Date 18-Sep-2025 Type D Description 1.50/share@30.00% Record Date 18-Sep-2025 Ratio 30.00

Ex-Date 25-Apr-2025 Type S Description share@1:2.00 Record Date 25-Apr-2025 Ratio 1:2.00

Ex-Date 13-Sep-2024 Type D Description 3.00/share@30.00% Record Date 13-Sep-2024 Ratio 30.00

Ex-Date 18-Sep-2023 Type D Description 3.00/share@30.00% Record Date 18-Sep-2023 Ratio 30.00

Ex-Date 29-Jul-2022 Type D Description 3.00/share@30.00% Record Date 01-Aug-2022 Ratio 30.00

Dividends

Announcement Date 18-Sep-2025 Ex Dividend Date 18-Sep-2025 Dividend(%) 30

Announcement Date 13-Sep-2024 Ex Dividend Date 13-Sep-2024 Dividend(%) 30

Announcement Date 18-Sep-2023 Ex Dividend Date 18-Sep-2023 Dividend(%) 30

Announcement Date 29-Jul-2022 Ex Dividend Date 29-Jul-2022 Dividend(%) 30

Bonus

No Bonus has been declared by ACUTAAS

Splits

Record Date 25-Apr-2025 Split Date 25-Apr-2025 Face Value (Before/After) 10.00/5.00

Others

Rights No Rights has been declared by ACUTAAS

Acutaas Chemicals Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Acutaas Chemicals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Acutaas Chemicals Ltd's relative performance and valuation against major competitors.

Stock Name Alembic Pharmaceuticals Ltd ₹921.95 (+0.72%) M. Cap (Cr) 181.22 1 Yr Return (%) -19.12% P/E (TTM) 28.57 PB Ratio 3.49

Stock Name Jubilant Pharmova Ltd ₹1127.20 (-2.90%) M. Cap (Cr) 179.56 1 Yr Return (%) -9.56% P/E (TTM) 37.58 PB Ratio 3.02

Stock Name Caplin Point Laboratories Ltd ₹1932.50 (-3.59%) M. Cap (Cr) 146.89 1 Yr Return (%) -7.77% P/E (TTM) 24.95 PB Ratio 5.78

Stock Name Acutaas Chemicals Ltd ₹1765.00 (-0.28%) M. Cap (Cr) 144.50 1 Yr Return (%) +69.39% P/E (TTM) 64.52 PB Ratio 12.02

Stock Name Natco Pharma Ltd ₹802.50 (+0.25%) M. Cap (Cr) 143.74 1 Yr Return (%) -44.55% P/E (TTM) 8.47 PB Ratio 1.89

Stock Name Granules India Ltd ₹554.65 (+0.43%) M. Cap (Cr) 134.60 1 Yr Return (%) -3.78% P/E (TTM) 28.07 PB Ratio 3.62

Stock Name Alivus Life Sciences Ltd ₹915.05 (+2.76%) M. Cap (Cr) 112.26 1 Yr Return (%) -16.67% P/E (TTM) 21.17 PB Ratio 3.98

Acutaas Chemicals Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Acutaas Chemicals Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 115.93

PARTICULARS Investing Activities Mar 2025 -234.37

PARTICULARS Financing Activities Mar 2025 273.56

PARTICULARS Net Cash Flow Mar 2025 155.12

Acutaas Chemicals Ltd Shareholding Pattern

This shows the ownership breakdown of Acutaas Chemicals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 32.66%

Public 27.89%

Other Institutions 6.79%

FII 16.84%

Mutual Funds 15.81%

About Acutaas Chemicals Ltd

Acutaas Chemicals Limited was initially formed as partnership firm in the name of Ami Organics on 3 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of Ami Organics Private Limited with a Certificate of Incorporation dated 12 June, 2007. Subsequently, the Company was converted into a Public Limited Company, reflecting the change in name of the Company to Ami Organics Limited on April 18, 2018. The name of the Company has now changed to Acutaas Chemicals Limited with effect from May 15, 2025, pursuant to the receipt of Fresh Certificate of Incorporation from the Registrar of Companies. The Company is engaged in business of drugs intermediate chemicals and related activities. The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015. It increased warehouse capacity, equipped with modern infrastructure & a storage capacity of 1,050 MT of RM in 2017.The Company commenced its new Solvent Recovery Plant at Sachin in 2020. It acquired two units namely, the Ankleshwar and Jhagadia units from Gujarat Organics Limited (GOL) in 2021. The Company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders, mopped up with a total of Rs 570 crore through its public issue in September, 2021. The Company incorporated wholly owned subsidiary Ami Organics Electrolytes Private Limited in 2023. The Company further embarked on setting brownfield project at Ankleshwar entailing a capex of Rs. 1900 Million. The existing Ankleshwar facility was demolished and work started to set up a new plant with advance technology for pharma intermediates business, scheduled to have installed capacity of 436.5 KL.The Company acquired a 55% stake in Baba Fine Chemicals (BFC) in FY 2024. The state-of-the-art technology driven plant in Ankleshwar Unit with the total reactor capacity of 442 KL for the manufacture of advanced pharmaceutical intermediate business with Distributed Control System (DCS) technology is made fully operational in FY 2025.

Chairman & Managing Director

Nareshbhai Ramjibhai Patel

Registered office Plot No 440/4 5&6, Road No 82/A GIDC Sachin, Surat, Gujarat, 394230

FAX :91-261-2397193/91-7227977744

Background

Incorporation Year 2007

Face Value ₹5.00

Market Lot 1

Acutaas Chemicals Ltd Latest News

VIEW MORE NEWS

FAQs on Acutaas Chemicals Ltd